OSAKA -- Researchers transplanted induced pluripotent stem cells derived from donors into a patient in Kobe Tuesday, in the first such trial using cells not from the patient -- an advance with hopeful implications for Japanese regenerative medicine.
Cheaper, prompter procedure opens doors to treating urgent ailments

Masayo Takahashi, right, head of the iPS donor cell transplant project at the Riken research institute, speaks to reporters after the procedure.
OSAKA -- Researchers transplanted induced pluripotent stem cells derived from donors into a patient in Kobe Tuesday, in the first such trial using cells not from the patient -- an advance with hopeful implications for Japanese regenerative medicine.